BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 28682928)

  • 21. Levetiracetam.
    Nash EM; Sangha KS
    Am J Health Syst Pharm; 2001 Jul; 58(13):1195-9. PubMed ID: 11449876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective analysis of the outcome of levetiracetam in clinical practice.
    Nicolson A; Lewis SA; Smith DF
    Neurology; 2004 Aug; 63(3):568-70. PubMed ID: 15304598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of levetiracetam for pediatric refractory epilepsy.
    Muramatsu K; Sawaura N; Ogata T; Makioka N; Tomita K; Motojima T; Ida K; Hazama K; Arakawa H
    Brain Dev; 2017 Mar; 39(3):231-235. PubMed ID: 27745925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous subcutaneous use of levetiracetam: a retrospective review of tolerability and clinical effects.
    Rémi C; Lorenzl S; Vyhnalek B; Rastorfer K; Feddersen B
    J Pain Palliat Care Pharmacother; 2014 Dec; 28(4):371-7. PubMed ID: 25313924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obsessive-compulsive behavior induced by levetiracetam.
    Fujikawa M; Kishimoto Y; Kakisaka Y; Jin K; Kato K; Iwasaki M; Nakasato N
    J Child Neurol; 2015 Jun; 30(7):942-4. PubMed ID: 25008911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Landau-Kleffner syndrome responsive to levetiracetam.
    Kossoff EH; Boatman D; Freeman JM
    Epilepsy Behav; 2003 Oct; 4(5):571-5. PubMed ID: 14527502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levetiracetam monotherapy during pregnancy: a case series.
    Long L
    Epilepsy Behav; 2003 Aug; 4(4):447-8. PubMed ID: 12899868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of a dose-response relationship of levetiracetam.
    Meencke HJ; Buyle S
    Eur J Neurol; 2006 Sep; 13(9):942-6. PubMed ID: 16930358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levetiracetam-induced reversible autistic regression.
    Camacho A; Espín JC; Nuñez N; Simón R
    Pediatr Neurol; 2012 Jul; 47(1):65-7. PubMed ID: 22704022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chorea in a patient with cerebral palsy: treatment with levetiracetam.
    Recio MV; Hauser RA; Louis ED; Radhashakar H; Sullivan KL; Zesiewicz TA
    Mov Disord; 2005 Jun; 20(6):762-4. PubMed ID: 15747368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy.
    Neyens LG; Alpherts WC; Aldenkamp AP
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 May; 19(3):411-9. PubMed ID: 7624492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of levetiracetam: a review of three pivotal clinical trials.
    Privitera M
    Epilepsia; 2001; 42 Suppl 4():31-5. PubMed ID: 11564123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B cell aplasia and hypogammaglobulinemia associated with levetiracetam.
    Ozdemir H; Sumer S; Karabagli H; Akdemir G; Caliskaner AZ; Artac H
    Ann Saudi Med; 2018; 38(1):65-68. PubMed ID: 29313528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of levetiracetam in refractory status epilepticus.
    Patel NC; Landan IR; Levin J; Szaflarski J; Wilner AN
    Seizure; 2006 Apr; 15(3):137-41. PubMed ID: 16426869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous levetiracetam in children with seizures: a prospective safety study.
    Ng YT; Hastriter EV; Cardenas JF; Khoury EM; Chapman KE
    J Child Neurol; 2010 May; 25(5):551-5. PubMed ID: 20413804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term levetiracetam treatment in patients with epilepsy: 3-year follow up.
    Kuba R; Novotná I; Brázdil M; Kocvarová J; Tyrlíková I; Mastík J; Rektor I
    Acta Neurol Scand; 2010 Feb; 121(2):83-8. PubMed ID: 20003081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombocytopenia as an adverse effect of levetiracetam therapy in a child.
    Peer Mohamed B; Prabhakar P
    Neuropediatrics; 2009 Oct; 40(5):243-4. PubMed ID: 20221962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levetiracetam-induced leukocytoclastic vasculitis.
    Gupta M
    Indian J Pharmacol; 2017; 49(1):124-126. PubMed ID: 28458437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levetiracetam: a different approach to the pharmacotherapy of epilepsy.
    Welty TE; Gidal BE; Ficker DM; Privitera MD
    Ann Pharmacother; 2002 Feb; 36(2):296-304. PubMed ID: 11847952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid dosage titration of levetiracetam in children.
    Vaisleib II; Neft RA
    Pharmacotherapy; 2008 Mar; 28(3):393-6. PubMed ID: 18294118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.